LifeMD, Inc. — Director's Dealing 2021

Sep 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-09-08

Reporting Person: BHATIA NAVEEN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-15	Common Stock	X	96349	$1.75	Acquired	96349	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-08	Stock Option (Right to Buy)	$7.07	A	100000	Acquired	2021-09-08	Common Stock (100000)	Direct
2021-09-08	Restricted Stock Unit	$0.00	A	8000	Acquired		Common Stock (8000)	Direct
2021-09-15	Warrant (Right to Buy)	$1.75	G	96349	Acquired	2022-01-12	Common Stock (96349)	Direct
2021-09-15	Warrant (Right to Buy)	$1.75	X	96349	Disposed	2022-01-12	Common Stock (96349)	Direct

Footnotes

F1: Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 8,000 Restricted Stock Units ("RSUs"), vesting quarterly with 25% vesting on September 30, 2021 and the remaining vesting ratably on December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. The RSUs represent a contingent right to receive one share of Common Stock for each RSU.

F2: Mr. Bhatia received an option to purchase 100,000 shares of Common Stock, at an exercise price of $7.07 per share, as compensation for services to be provided pursuant to a Consulting Agreement dated September 8, 2021.